Unknown

Dataset Information

0

Cartilage tissue engineering identifies abnormal human induced pluripotent stem cells.

ABSTRACT: Safety is the foremost issue in all human cell therapies, but human induced pluripotent stem cells (iPSCs) currently lack a useful safety indicator. Studies in chimeric mice have demonstrated that certain lines of iPSCs are tumorigenic; however a similar screen has not been developed for human iPSCs. Here, we show that in vitro cartilage tissue engineering is an excellent tool for screening human iPSC lines for tumorigenic potential. Although all human embryonic stem cells (ESCs) and most iPSC lines tested formed cartilage safely, certain human iPSCs displayed a pro-oncogenic state, as indicated by the presence of secretory tumors during cartilage differentiation in vitro. We observed five abnormal iPSC clones amoungst 21 lines derived from five different reprogramming methods using three cellular origins. We conclude that in vitro cartilage tissue engineering is a useful approach to identify abnormal human iPSC lines.

SUBMITTER: Yamashita A 

PROVIDER: S-EPMC3680803 | biostudies-other | 2013

REPOSITORIES: biostudies-other

Json Xml
altmetric image

Publications

Cartilage tissue engineering identifies abnormal human induced pluripotent stem cells.

Yamashita Akihiro A   Liu Shiying S   Woltjen Knut K   Thomas Bradley B   Meng Guoliang G   Hotta Akitsu A   Takahashi Kazutoshi K   Ellis James J   Yamanaka Shinya S   Rancourt Derrick E DE  

Scientific reports 20130101

Safety is the foremost issue in all human cell therapies, but human induced pluripotent stem cells (iPSCs) currently lack a useful safety indicator. Studies in chimeric mice have demonstrated that certain lines of iPSCs are tumorigenic; however a similar screen has not been developed for human iPSCs. Here, we show that in vitro cartilage tissue engineering is an excellent tool for screening human iPSC lines for tumorigenic potential. Although all human embryonic stem cells (ESCs) and most iPSC l  ...[more]

Similar Datasets

Unknown Cartilage tissue engineering using differentiated and purified induced pluripotent stem cells.
| S-EPMC3511083 | biostudies-other
Unknown Engineering bone tissue substitutes from human induced pluripotent stem cells.
| S-EPMC3666730 | biostudies-literature
Unknown Induced pluripotent stem cells for neural tissue engineering.
| S-EPMC3100451 | biostudies-literature
Unknown Engineering human pluripotent stem cells into a functional skeletal muscle tissue.
| S-EPMC5760720 | biostudies-literature
Unknown Trichostatin A enhances differentiation of human induced pluripotent stem cells to cardiogenic cells for cardiac tissue engineering.
| S-EPMC3754471 | biostudies-literature
Unknown Xenogeneic-free generation of vascular smooth muscle cells from human induced pluripotent stem cells for vascular tissue engineering.
| S-EPMC8168373 | biostudies-literature
Unknown Characterizing human pluripotent-stem-cell-derived vascular cells for tissue engineering applications.
| S-EPMC4313392 | biostudies-literature
Unknown Efficient Differentiation of Human Induced Pluripotent Stem Cells into Endothelial Cells under Xenogeneic-free Conditions for Vascular Tissue Engineering.
| S-EPMC8133308 | biostudies-literature
Transcriptomics Engineering Bone Tissue Substitutes from Human Induced Pluripotent Stem Cells
2013-04-24 | E-GEOD-46315 | biostudies-arrayexpress
Unknown Propagation of human prostate tissue from induced pluripotent stem cells.
| S-EPMC7308643 | biostudies-literature